Sugi Predict

Sugi Predict / Compounds / SCHEMBL1414705

SCHEMBL1414705

SCHEMBL1414705

Cc1ccc(S(=O)(=O)OC(F)C(F)F)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AGER Q15109 1/20 0.46
▸ GAA P10253 3/20 0.45
▸ CA1 P00915 3/20 0.42
▸ CA2 P00918 3/20 0.42
▸ CA12 O43570 1/20 0.42
▸ CA3 P07451 1/20 0.42
▸ CA6 P23280 1/20 0.42
▸ CA5A P35218 1/20 0.42
▸ CA7 P43166 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ CA5B Q9Y2D0 1/20 0.42
▸ VDR P11473 1/20 0.41
▸ TLR9 Q9NR96 1/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ ALDH1A1 P00352 3/20 0.38
▸ MMP1 P03956 1/20 0.38
▸ MMP2 P08253 1/20 0.38
▸ MMP9 P14780 1/20 0.38
▸ MMP8 P22894 1/20 0.38
▸ MMP13 P45452 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28269568 0.89 AGER (0.43) AGERGAACA1CA2CA12
SCHEMBL29224493 0.85 AGER (0.46) AGERGAACA1CA2CA12
SCHEMBL872063 0.84 AGER (0.48) AGERGAACA1CA2CA12
SCHEMBL9711306 0.84 AGER (0.42) AGERGAACA1CA2CA12
SCHEMBL10402377 0.83 AGER (0.44) AGERGAACA1CA2CA12
SCHEMBL242207 0.82 AGER (0.47) AGERGAACA1CA2CA12
SCHEMBL15387355 0.82 AGER (0.41) AGERGAACA1CA2CA12
SCHEMBL8136184 0.80 HTR6 (0.41) CA1CA2CA12CA3CA6
SCHEMBL2342945 0.79 GAA (0.52) AGERGAACA1CA2CA12
SCHEMBL5557903 0.79 GAA (0.52) AGERGAACA1CA2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109476874-A Bi-component cyanoacrylate curable adhesive system 汉高知识产权控股有限责任公司 2019-03-15 — — CN claimed
CN-108473821-A Cyanoacrylate compositions 汉高知识产权控股有限责任公司 2018-08-31 — — CN claimed
CN-108463525-A CYANOACRYLATE COMPOSITIONS 汉高知识产权控股有限责任公司 2018-08-28 — — CN claimed
CN-102827319-B The preparation method of a kind of vanadium series catalyst and preparation method thereof and ethylene-propylene copolymer CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY CHINESE ACADEMY OF SCIENCES (CN) 2015-08-05 — — CN claimed
CN-102617763-B Preparation method of ultrahigh molecular weight polyethylene CHANGCHUN APPLIED CHEMISTRY 2014-02-12 — — CN claimed
CN-102627708-B Preparation method for high-activity Ziegler Natta catalyst and application thereof CHANGCHUN APPLIED CHEMISTRY 2014-02-12 — — CN claimed
CN-102627712-B Preparation method and application of Ziegler Natta catalyst for propylene polymerization CHANGCHUN APPLIED CHEMISTRY 2014-02-12 — — CN claimed
CN-102827319-A Vanadium catalyst and preparation method of vanadium catalyst as well as preparation method of ethylene-propylene copolymer CHANGCHUN APPLIED CHEMISTRY 2012-12-19 — — CN claimed
CN-102627712-A Preparation method and application of Ziegler Natta catalyst for propylene polymerization CHANGCHUN APPLIED CHEMISTRY 2012-08-08 — — CN claimed
CN-102627708-A Preparation method for high-activity Ziegler Natta catalyst and application thereof CHANGCHUN APPLIED CHEMISTRY 2012-08-08 — — CN claimed
CN-102617763-A Preparation method of ultrahigh molecular weight polyethylene CHANGCHUN APPLIED CHEMISTRY 2012-08-01 — — CN claimed
US-5047559-A Multistep Reaction Beginning With 3-Amino-4-Methylphenol UNITED STATES DEPARTMENT OF ENERGY (US) 1991-09-10 — — US claimed
CN-115724799-B Potassium channel regulator, composition and application 纽欧申医药(上海)有限公司 2025-05-13 — — CN disclosed
CN-113490670-B Nitrogen-containing polycyclic condensed ring compound, pharmaceutical composition, preparation method and application thereof 北京志健金瑞生物医药科技有限公司 2023-06-02 — — CN disclosed
US-11247981-B2 Metalloenzyme inhibitor compounds Mycovia Pharmaceuticals, Inc. (US) 2022-02-15 — — US disclosed
EP-3302484-B1 6-ALKYL DIHYDROPYRAZOLOPYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS MERCK SHARP & DOHME (US) 2020-09-16 — — EP disclosed
US-5111472-A Rhodamine dye, 540 to 570 nm THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) 1992-05-05 — — US disclosed
US-5047559-A Multistep Reaction Beginning With 3-Amino-4-Methylphenol UNITED STATES DEPARTMENT OF ENERGY (US) 1991-09-10 — — US disclosed
US-4992560-A Condensation of N-monoalkylated 3-amino-4-methylphenol with phthalic anhydride THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) 1991-02-12 — — US disclosed
US-4945176-A Novel fluorinated laser dyes THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) 1990-07-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11247981-B2 Metalloenzyme inhibitor compounds MMEL1, GPX1, MPO AGER 936/4885GAA 6/4885CA1 356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.